Deutsch Englisch Englisch Englisch Legal Information

3-D structure of human insulin hexamer viewed along the 3-fold symmetry axis, visualised with PyMOL(TM) v0.99 Software, copyright (C) 2006, by courtesy of DeLano Scientific LLC



Worldwide increasing incidence of Diabetes mellitus needs constant growth of insulin as therapeutic agent. Cost-efficient production of insulin is necessary to reduce health care costs. GlucoMetrix develops new technology to produce cheaper insulin. Clinical trials should start in 2012 and large-scale production is scheduled for 2014/2015.


Europäischer Fonds für regionale Entwicklung

GlucoMetrix plc ©2008 | All rights reserved